Long-haul COVID Roundtable

Discussing the impact of long-haul COVID on drug development with key industry experts

Parexel and PharmExec hosted a virtual roundtable of experts to discuss the impact of post-acute sequelae of SARS-CoV-2 (PASC) — otherwise known as Long COVID, post-COVID conditions and/or long-haul COVID – and the challenges faced in research and diagnosis of this complex condition. 

Clare Grace, Chief Patient Officer; Nathalie Sohier, Senior Vice President, Global Head for Infectious Diseases and Vaccines Franchise; Michelle Hoiseth, Chief Data Officer and Fran Oko, Senior Solutions Consultant Director participated with 11 other experts from various stakeholder groups. The roundtable covered the following topics:

 

  • Current research into long COVID
  • Disparate theories of causes
  • Challenges in research and diagnosis
  • Long COVID potential in drug development

 

Please check out the article resulting from the roundtable discussion along with videos spotlighting Parexel’s perspectives based on the discussion:

Download the roundtable article

We are always available for a conversation.

*  

We are always available for a conversation.

Submitting...

Communication Preference

Communication Preference